ADAPTIVE PHASE-I STUDY OF OROS-METHYLPHENIDATE TREATMENT OF ADHD WITH EPILEPSY

OBJECTIVE: To pilot a randomized controlled trial of OROS-Methylphenidate (MPH) to treat ADHD plus epilepsy. METHOD: Thirty-three patients, 6–18 years, taking antiepileptic drugs and with a last seizure 1–60 months prior were assigned to a maximum daily dose of 18, 36, or 54mg of OROS-MPH in a doubl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gonzalez-Heydrich, Joseph, Whitney, Jane, Waber, Deborah, Forbes, Peter, Hsin, Olivia, Faraone, Stephen V., Dodds, Alice, Rao, Sneha, Mrakotsky, Christine, MacMillan, Carlene, DeMaso, David R., de Moor, Carl, Torres, Alcy, Bourgeois, Blaise, Biederman, Joseph
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2902631/
https://ncbi.nlm.nih.gov/pubmed/20493783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.yebeh.2010.02.022
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars